Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human CLEC2D Anticorps:
anti-Mouse (Murine) CLEC2D Anticorps:
anti-Rat (Rattus) CLEC2D Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal CLEC2D Primary Antibody pour IHC (p), ELISA - ABIN565412
Roth, Mittelbronn, Wick, Meyermann, Tatagiba, Weller: Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1. dans Cancer research 2007
Show all 6 Pubmed References
Human Monoclonal CLEC2D Primary Antibody pour ELISA, WB - ABIN949236
Williams, Eaton, Jones, Rengan, Burshtyn: Vaccinia virus Western Reserve induces rapid surface expression of a host molecule detected by the antibody 4C7 that is distinct from CLEC2D. dans Microbiology and immunology 2016
Human Polyclonal CLEC2D Primary Antibody pour CyTOF, FACS - ABIN4900423
Llibre, Garner, Partridge, Freeman, Klenerman, Willberg: Expression of lectin-like transcript-1 in human tissues. dans F1000Research 2017
Human Monoclonal CLEC2D Primary Antibody pour FACS - ABIN4897677
Dupuy, Lambert, Zucman, Choukem, Tognarelli, Pages, Lebbé, Caillat-Zucman: Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. dans PLoS pathogens 2012
Human Monoclonal CLEC2D Primary Antibody pour FACS - ABIN4897676
Chalan, Bijzet, Huitema, Kroesen, Brouwer, Boots: Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. dans PLoS ONE 2015
Blocking LLT1-NKRP1A (Montrer KLRB1 Anticorps) interaction will make prostate cancer cells susceptible to killing by NK cells, suggesting a therapeutic option for treatment of prostate cancer.
these data suggest that LLT1-CD161 (Montrer KLRB1 Anticorps) interactions play a novel and important role in B cell maturation (Montrer TNFRSF17 Anticorps) within the Germinal center in humans.
In RA joints, LLT1 is expressed by cells of the monocyte/macrophage lineage.
The hexamer of glycosylated LLT1 consists of three classical dimers. The hexameric packing may indicate a possible mode of interaction of C-type lectin (Montrer MBL2 Anticorps)-like proteins in the glycosylated form.
One polymorphism in LLT1 was found to be associated with our Crohn's Disease population (P<0.034).Our Ulcerative Colitis cohort was not associated with the variation in LLT1 (P=0.33)
LLT1 and CD161 (Montrer KLRB1 Anticorps) have roles in modulating immune responses to pathogens; and interferon-gamma (Montrer IFNG Anticorps) contributes to modulate immune responses
Molecular basis for LLT1 protein recognition by human CD161 (Montrer KLRB1 Anticorps) protein (NKRP1A/KLRB1 (Montrer KLRB1 Anticorps)).
Data show that only CLEC2D isoform 1 (LLT1) is expressed on the cell surface.
LLT1 used Src (Montrer SRC Anticorps)-PTK, p38 (Montrer CRK Anticorps) and ERK (Montrer EPHB2 Anticorps) signalling pathways, but not PKC (Montrer PRRT2 Anticorps), PI3K (Montrer PIK3CA Anticorps) or calcineurin pathways, to increase production of IFN-gamma (Montrer IFNG Anticorps) by human natural killer cells.
LLT1 induces Interferon (Montrer IFNA Anticorps) Type II production by natural killer cells.
Data suggest that killer cell lectin-like receptors NKR (Montrer TACR3 Anticorps)-P1B:Clr-b (Klrb1 (Montrer KLRB1 Anticorps):Clec2d) interactions may provide a model for human hematopoietic cell transplants.
Reductions of Clr-b may be involved in sensitizing poxvirus-infected cells to natural killer (NK) cells.
LLT1 and CD161 have roles in modulating immune responses to pathogens; and interferon-gamma (Montrer IFNG Anticorps) contributes to modulate immune responses
cloning and characterization of a cognate ligand, Ocil, for the inhibitory NK receptors (NKR)-P1B and NKR-P1D. Ocil/Clr-b is displayed at high levels on nearly all hematopoietic cells, in a pattern that is similar to that of class I MHC molecules.
Data show that osteoclast inhibitory lectin (OCIL) binds a range of physiologically important glycosaminoglycans, and this property may modulate OCIL actions upon other cells.
Limited divergence of the BALB/c Nkrp1-Ocil/Clr region helps explain a longstanding confusion regarding the strain-specific NK1.1 alloantigen reactivity of mouse natural killer cells.
OCIL is a physiological negative regulator of bone.
PTHrp(1-34) regulates OCIL expression in vitro through cAMP/PKA, Ca(2 (Montrer CA2 Anticorps)+)/CaMK II (Montrer CAMK2B Anticorps), and MAPK (Montrer MAPK1 Anticorps) signaling pathways.
Identification of a novel family of genes, named Clr (Montrer CALCR Anticorps), encoding C-type lectin-like molecules, which maps in the natural killer (NK) gene complex (NKC) on mouse Chromosome 6.
Mouse Nkrp1d and Nkrp1f bind specific C-type lectin-related (Clr (Montrer CALCR Anticorps)) molecules. Nkrp1d mediated inhibition when recognizing Clrb, a molecule expressed in dendritic cells and macrophages. Nkrp1 and Clr (Montrer CALCR Anticorps) are intertwined in a genetically conserved NKC region.
This gene encodes a member of the natural killer cell receptor C-type lectin family. The encoded protein inhibits osteoclast formation and contains a transmembrane domain near the N-terminus as well as the C-type lectin-like extracellular domain. Several alternatively spliced transcript variants have been identified for this gene.
C-type lectin domain family 2 member D
, C-type lectin related f
, C-type lectin superfamily 2, member D
, lectin-like NK cell receptor
, lectin-like transcript 1
, osteoclast inhibitory lectin
, C-type lectin-domain family 2 member D
, C-type lectin-related protein B
, lectin-like transmembrane protein
, C-type lectin domain family 2 member D5
, C-type lectin domain family 2, member D
, C-type lectin domain family 2 member H-like